Literature DB >> 6729410

Psychophysiological dysfunctions in the developmental course of schizophrenic disorders.

M E Dawson, K H Nuechterlein.   

Abstract

Psychophysiological anomalies in symptomatic schizophrenic patients, remitted schizophrenic patients, and individuals at heightened risk for a schizophrenic disorder are reviewed with an emphasis on electrodermal anomalies. Two electrodermal anomalies are identified in different subgroups of symptomatic patients: (1) an abnormally high sympathetic arousal and (2) an abnormal absence of skin conductance orienting responses to innocuous environmental stimuli. The same two electrodermal anomalies also have been observed in remitted schizophrenic patients. Among high-risk individuals, the offspring of schizophrenic patients display abnormally high electrodermal responsiveness to aversive stimulation, whereas a substantial proportion of college students who score high on physical anhedonia (a putative risk factor for schizophrenia) exhibit skin conductance nonresponsiveness. Thus, heightened sensitivity to aversive stimulation appears to be associated with a genetic vulnerability to schizophrenia, while tonic hyperarousal , which occurs in subgroups of symptomatic and remitted schizophrenic patients, may reflect a later developmental consequence of the underlying vulnerability. Skin conductance nonresponsivity may represent a different developmental consequence associated with the same underlying vulnerability or it may represent a different type of vulnerability. Other psychophysiological anomalies also are promising indicators of the vulnerability to schizophrenia (e.g., deviant smooth pursuit eye movements, attenuated P300 component of the event-related brain potential, reduced electroencephalic (EEG) alpha activity, and heightened EEG delta activity).

Entities:  

Mesh:

Year:  1984        PMID: 6729410     DOI: 10.1093/schbul/10.2.204

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  13 in total

Review 1.  Determinants of functioning and well-being among individuals with schizophrenia: an integrated model.

Authors:  P T Yanos; R H Moos
Journal:  Clin Psychol Rev       Date:  2006-02-09

Review 2.  Effects of neuroleptics on electrodermal activity in schizophrenic patients: a review.

Authors:  D B Schnur
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Empathy in electrodermal responsive and nonresponsive patients with schizophrenia.

Authors:  Satoru Ikezawa; Silvia Corbera; Jiacheng Liu; Bruce E Wexler
Journal:  Schizophr Res       Date:  2012-10-09       Impact factor: 4.939

4.  The interaction of electrodermal activity and expressed emotion in predicting symptoms in recent-onset schizophrenia.

Authors:  Kenneth L Subotnik; Anne M Schell; Mark S Chilingar; Michael E Dawson; Joseph Ventura; Kimberle A Kelly; Gerhard S Hellemann; Keith H Nuechterlein
Journal:  Psychophysiology       Date:  2012-06-08       Impact factor: 4.016

5.  Deconstructing processing speed deficits in schizophrenia: application of a parametric digit symbol coding test.

Authors:  Peter Bachman; Abraham Reichenberg; Patrick Rice; Mary Woolsey; Olga Chaves; David Martinez; Natalie Maples; Dawn I Velligan; David C Glahn
Journal:  Schizophr Res       Date:  2010-03-02       Impact factor: 4.939

6.  Stress-response-dampening effects of alcohol: attention as a mediator and moderator.

Authors:  Kenneth J Sher; Bruce D Bartholow; Karl Peuser; Darin J Erickson; Mark D Wood
Journal:  J Abnorm Psychol       Date:  2007-05

7.  Design of a Virtual Reality System for Affect Analysis in Facial Expressions (VR-SAAFE); Application to Schizophrenia.

Authors:  E Bekele; D Bian; J Peterman; S Park; N Sarkar
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2016-07-14       Impact factor: 3.802

Review 8.  Leveraging the cortical cholinergic system to enhance attention.

Authors:  Elise Demeter; Martin Sarter
Journal:  Neuropharmacology       Date:  2012-07-13       Impact factor: 5.250

9.  Exploration of auditory P50 gating in schizophrenia by way of difference waves.

Authors:  Sidse M Arnfred
Journal:  Behav Brain Funct       Date:  2006-01-28       Impact factor: 3.759

Review 10.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.